Chlorpromazine-D3 is a deuterated derivative of chlorpromazine, which is an antipsychotic medication primarily used to treat schizophrenia and other mental health disorders. The deuteration refers to the substitution of hydrogen atoms with deuterium, a stable isotope of hydrogen, which can enhance the compound's stability and alter its pharmacokinetic properties. Chlorpromazine itself is a phenothiazine derivative, characterized by its ability to block dopamine receptors in the brain, thereby exerting its antipsychotic effects. The presence of deuterium in Chlorpromazine-D3 can be useful in research applications, particularly in pharmacokinetic studies and metabolic tracing, as it allows for the differentiation of the compound from its non-deuterated counterpart in biological systems. This compound is typically utilized in scientific research rather than clinical settings, and its characteristics include a similar pharmacological profile to chlorpromazine, with modifications that may affect its solubility, stability, and interaction with biological targets. As with any chemical substance, safety and handling precautions should be observed.

CHLORPROMAZINE-D3

136765-28-1: Chlorpromazine-D3 is a deuterated derivative of chlorpromazine, which is an antipsychotic medication primarily used to treat schizophrenia and other mental health disorders. The deuteration refers to the substitution of hydrogen atoms with deuterium, a stable isotope of hydrogen, which can enhance the compound's stability and alter its pharmacokinetic properties. Chlorpromazine itself is a phenothiazine derivative, characterized by its ability to block dopamine receptors in the brain, thereby exerting its antipsychotic effects. The presence of deuterium in Chlorpromazine-D3 can be useful in research applications, particularly in pharmacokinetic studies and metabolic tracing, as it allows for the differentiation of the compound from its non-deuterated counterpart in biological systems. This compound is typically utilized in scientific research rather than clinical settings, and its characteristics include a similar pharmacological profile to chlorpromazine, with modifications that may affect its solubility, stability, and interaction with biological targets. As with any chemical substance, safety and handling precautions should be observed.

CAS 136765-28-1

CHLORPROMAZINE-D3

Chlorpromazine-D3 0.1 mg/ml in Methanol

Ref: 61-AMP0420.80-02